Connect with us

Hi, what are you looking for?

Stock

Germany’s DAX closes above 20,000 mark; France’s no-confidence vote eyed

By Joao Manuel Vicente Mauricio, Ankika Biswas and Johann M Cherian

(Reuters) -European closed at a fresh one-month high on Wednesday, with German stocks finishing above the 20,000 mark, while attention was on France where a no-confidence vote in parliament was likely oust Prime Minister Michel Barnier’s government.

The pan-European STOXX 600 index closed higher by 0.3% and notched its fifth straight session of advances, with retail stocks leading sectoral advances by 2.2%.

France’s CAC 40 closed up 0.6% as the debate on the no-confidence motion was underway ahead of the vote due around 1830-1900 GMT.

Barnier’s three-month old fragile government is expected to be forced out at a time when the country is struggling to tame a massive budget deficit, and French President Emmanuel Macron said he aims to install a new prime minister quickly if his government falls.

“There is clearly a decent level of uncertainty and division within France around the right way forward,” said Richard Flax, chief investment officer at Moneyfarm.

“Whatever budget gets eventually put forward, or even whether (the current budget) is rolled over, the challenge of resolving these fiscal and debt dynamics is that it is a multi-year process.”

France’s political uncertainty also hit its services sector, data showed, while the euro zone’s business activity fell sharply.

Political chaos in France has weighed on the CAC 40 which is down over 3% this year and is the top decliner among peers. The euro has lost over 4% this year, while spreads between French and German bonds have widened to a 12-year high.[GVD/EUR]

On Tuesday, Germany’s DAX rose 1% and closed above the 20,000-point mark for the first time, boosted by SAP’s 3.7% advance.

Among others, Vestas bottomed the STOXX index with a 10.9% slide after the Danish wind turbine maker said CFO Hans Martin Smith would step down by end-2024.

Signify lost 4.3% after Barclays (LON:BARC) downgraded the stock of the lighting maker to “underweight” from “overweight”.

Meanwhile, AstraZeneca (NASDAQ:AZN) and Novartis (SIX:NOVN) lost around 3% each, dragging down the healthcare index, after HSBC cut the target price of the former and downgraded the latter to “reduce” from “hold”.

Hugo Boss (ETR:BOSSn) surged 9.7% after Baader Helvea upgraded its rating on the German fashion house to “buy” from “add”.

Hexagon jumped 7.8% after the company proposed the former CEO of ABB (ST:ABB) and Sandvik as the new vice chairman.

The auto sector was among top sectoral gainer, with Stellantis (NYSE:STLA) rising 1.3% after a report said that Apple (NASDAQ:AAPL)’s outgoing CFO could become the new CEO of the Italian-French carmaker. However, the company later denied these claims.

This post appeared first on investing.com






    You May Also Like

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Editor's Pick

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Latest News

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com